Clinical trial on the QOL of the Tegafur/Uracil plus Leucovolin(UFT/LV) to adjuvant chemotherapy for the Stage II, III colorectal cancer - Clinical trial on the QOL of the Tegafur/Uracil plus Leucovolin(UFT/LV) to adjuvant chemotherapy. (KODK8)

Department of Surgery Keio University School of Medicine0 个研究点目标入组 400 人开始时间: 2012年9月25日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)with active synchronous or metachronous malignancy other than carcinoma in situ(within 5 years). (2)Synchronous or metachronous malignancy other than carcinoma in situ 3)has severe postoperative complications such as serious postoperative infectious disease,anastomotic leak and gastrointestinal bleeding. 4)has any of the following complications: i)Uncontrollable diabetes mellitus ii)Uncontrollable hypertension iii) heart failure within 6 months,myocardial infarction,AP or sever abnormality of ECG iv)renal failure v)interstitial pneumonitis,lung fibrosis or severe emphysema . 5)has any of the following : i)is a pregnant woman or a woman suspected of being pregnant,or,is a man who hopes to make his partner pregnant ii)nursing women 6)with psychosis or psychoneurosis. 7)In case that the doctor judged that he/she is disqualified for the enrollment in this clinical trial.

发起方

Department of Surgery Keio University School of Medicine